SC16LD6.5 (Clinical Trials)

TrialTitleStudy Record DetailPhaseSponsor/Collaborator
SC16LD6.5 in Recurrent Small Cell Lung CancerNCT01901653Phase I / Phase IIStem CentRx, Inc.

Drug description